Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Gender identity can be more diverse than just male or female.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

The surgical technique of scalp advancement and pretrichial brow lift shortens the forehead and lifts brows, is good for women and transgender women with high foreheads, but not recommended for men and has some risks.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The conclusion is that sex-verification in sports was harmful and changes have been made to address this.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

More research is needed to improve lower body gender affirmation techniques.